Keros Therapeutics
KROS | NASDAQ
$10.03
-$0.27 (-2.62%)
At close: Nov 16, 2026, 4:00 PM ET
$10.18
+$0.15 (+1.50%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Keros Therapeutics Statistics
Key statistics explainedMarket Data
$373.33M
$128.97M
1.02
211.87K
37.86M
N/A
94.51%
NASDAQ
US4923271013
Price Performance
-5.9%
-4.3%
-1.3%
-50.7%
-42.3%
-66.9%
-83.4%
-5.9%
-41.9%
-30.4%
-9.6%
Valuation
-2.85
N/A
0.01
0.01
9.16
22.90
1.34
-7.73
-5.23
-4.16
3.16
-1.67
-2.04
-2.67
-35.1%
-12.9%
-19.1%
Financial Health
$244.35M
$15.11M
$259.46M
$307.37M
18.14
18.14
0.05
-0.24
-0.31
-3.17
0.00
6.13
2
Margins & Profitability
98.0%
-179.8%
-150.3%
-151.4%
-118.4%
-175.1%
56.6%
-47.8%
Returns
-20.1%
-21.9%
-24.6%
-25.1%
-20.1%
Historical Growth (CAGR)
1620.8%
232.7%
N/A
40.0%
17.7%
N/A
136.3%
42.6%
N/A
Analyst Forecasts
Buy
3
0.2%
20.3%
Mar 3, 2027
-$1.63
89.3%
$600K
55.8%
Fair Value Estimates
N/A
N/A
N/A
N/A
$20.00
99.4%
Cash Flow
$-47.85M
$-48.27M
$-71.36M
-$2.43
-$2.41
-117.4%
Income Statement
$40.76M
$349K
$-73.27M
$-63.37M
$-61.73M
-$3.52
$443.05K
$-670.93K
92
Add to Watchlist
Select watchlists to add or remove KROS